PCV38 A PHARMACOECONOMIC EVALUATION ON IRBESARTAN AND LEVOAMLODIPINE IN STROKE AND MYOCARDIAL INFARCTION PREVENTION AMONG HYPERTENSION PATIENTS IN CHINA
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.474
https://www.valueinhealthjournal.com/article/S1098-3015(19)30666-7/fulltext
Section Title :
Section Order :
10116
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30666-7&doi=10.1016/j.jval.2019.04.474